Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition

Hélène Salmon(Icahn School of Medicine at Mount Sinai), Juliana Idoyaga(Stanford University), Adeeb Rahman(Icahn School of Medicine at Mount Sinai), Marylène Leboeuf(Icahn School of Medicine at Mount Sinai), Romain Remark(Icahn School of Medicine at Mount Sinai), Stefan Jordan(Icahn School of Medicine at Mount Sinai), María Casanova-Acebes(Icahn School of Medicine at Mount Sinai), Makhzuna N. Khudoynazarova(Icahn School of Medicine at Mount Sinai), Judith Agudo(Icahn School of Medicine at Mount Sinai), Navpreet Tung(Icahn School of Medicine at Mount Sinai), Svetoslav Chakarov(Agency for Science, Technology and Research), Christina G. Rivera(Icahn School of Medicine at Mount Sinai), Brandon Hogstad(Icahn School of Medicine at Mount Sinai), Marcus Bosenberg(Yale University), Daigo Hashimoto(Hokkaido University), Sacha Gnjatic(Icahn School of Medicine at Mount Sinai), Nina Bhardwaj(Icahn School of Medicine at Mount Sinai), A. Karolina Palucka(Jackson Laboratory), Brian D. Brown(Icahn School of Medicine at Mount Sinai), Joshua Brody(Icahn School of Medicine at Mount Sinai), Florent Ginhoux(Agency for Science, Technology and Research), Miriam Mérad(Icahn School of Medicine at Mount Sinai)
Immunity
April 1, 2016
10.1016/j.immuni.2016.03.012
Cited by 1,161Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis